Jul 18, 2012
Elekta grant to support paediatric cancer research in Spain
MADRID, 17 July 2012 – To support research exploring childhood cancers, Elekta has given a 32,000 € (ca. 40,000 USD) grant to Madrid Hospital Foundation’s Pediatric Oncology program at the Madrid Montepríncipe Hospital's Pediatric Oncology and Hematology Unit. The donation was collected at a charity party held in conjunction with the 2012 Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO, May 9-12) in Barcelona.
The Foundation’s Pediatric Oncology research programs focus on increasing the understanding of cancer in children, and on improving treatment methods and the patient’s quality of life.
At a gala presentation in June at the Hospitales de Madrid, the money officially was donated. Dr. Juan Abarca and Dr. Blanca López-Ibor represented Hospitales de Madrid, while Massimo Abbiatti and Eduardo Rodríguez Urcelay attended on behalf of Elekta.
“Because cancer occurs more often in adults than in children, most of today’s technological developments in radiation therapy focus on adult patients and their needs,” says Elekta’s President and CEO, Tomas Puusepp. “To address this imbalance, we are pleased to support the efforts of worthy pediatric cancer research programs such as the Foundation’s Pediatric Oncology program. Elekta’s own efforts are aimed at adapting radiation therapy treatments to children, such as developing more suitable immobilization devices and imaging strategies, and by studying how to adjust doses for pediatric patients. To that end, we recently created the Elekta Pediatric Research Group, whose mission is to identify, develop and adapt products to treat childhood cancer."
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.